Black Diamond Therapeutics Company

Black Diamond Therapeutics is a precision oncology medicine company pioneering the discovery and development of small molecule.
Industry: End-to-end Drug Development
Headquarters: Cambridge, Massachusetts, United States
Founded Date: 2017-01-01
Employees Number: 1-10
Funding Status: IPO
Investors Number: 16
Total Funding: 197100000
Estimated Revenue: $10M to $50M
Last Funding Date: 2019-12-05
Last Funding Type: Series C

Visit Website
info@bdtherapeutics.com
Register and Claim Ownership